 The "statin" family of cholesterol-reducing medications inhibits HMG-CoA reductase.One possible side effect of statins is decreased production of CoQ10, which may be connected to the development of myopathy and rhabdomyolysis.However, the role statin plays in CoQ deficiency is controversial.